Wednesday 23rd November 2022 |
Text too small? |
Serko Limited (NZX: SKO ) today announces its unaudited financial results for the six month period ended 30 September 2022.
Summary of Financial Results:1,2
• Total income $19.4 million, up 106%
• Segment revenue $20.3 million, up 106%
• Average revenue per booking $7.85, up 54%
• Total travel booking volumes 2.3 million, up 73%
• Completed room nights on Booking.com for Business 454,000, up 432%
• EBITDAF $16.9 million, an increase of 44%
• Net losses after tax $19.7 million, an increase of 30%
• Cash and short-term deposits $102.9 million
• Average monthly cash burn $3.6 million
• Serko targeting return to cashflow positive during FY25
• FY23 revenue guidance affirmed.
All dollar amounts are New Zealand dollars, unless otherwise stated.
Please find attached the following documents containing additional information:
- Market Release
- Results Announcement (NZX Appendix 2)
- Half Year Financial Statements
- Investor Presentation
These documents will also be made available on: www.serko.com/investor-centre
Half-year Results Call
The half-year results will be discussed on a conference call at 11.00am (NZT) today.
To participate in the call dial one of the following numbers. The call confirmation code is 595514
Location Purpose Phone Type Phone Number
New Zealand Dial-in Tollfree/Freephone 0800 423 972
New Zealand, Auckland Dial-in Local +64 (0)9 9133 624
Australia Dial-in Tollfree/Freephone 1 800 590 693
Australia, Sydney Dial-in Local +61 (0)2 7250 5438
Hong Kong, Hong Kong Dial-in Local +852 5803 0798
Singapore Dial-in Tollfree/Freephone 800 120 7297
United Kingdom Dial-in Tollfree/Freephone 0800 358 6374
United Kingdom, Local Dial-in Local +44 (0)330 165 3646
United States/Canada Dial-in Tollfree/Freephone 800-289-0459
Or click on the below link that will also take you to the conference call: https://event.webcasts.com/starthere.jsp?ei=1579420&tp_key=e4c650ec1b
There is no pre-registration required for the conference call.
For and on behalf of Serko by Shane Sampson, Chief Financial Officer.
Ends
No comments yet
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report
RAD - Radius Care Announces On-market Share Buyback Programme
MCY - New wind farm propels MCY renewables commitment to $1b